MusclePharm: MusclePharm : Accelaration/Increase of Financial Obligation - Form 8-K

(marketscreener.com) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : August 26, 2022 MusclePharm...https://www.marketscreener.com/quote/stock/MUSCLEPHARM-CORPORATION-120792970/news/MusclePharm-Accelaration-Increase-of-Financial-Obligation-Form-8-K-41804698/?utm_medium=RSS&utm_content=20220919